JOSEPH KANON

Corporate Board Profile

Tech Score: 0/100

Protagenic Therapeutics, Inc.\new

Filing Date	Source Excerpt
2001-10-31	JOSEPH KANON has served as a director of the Company since November 1999. Mr. Kanon served as Executive Vice President for Trade and Reference Publishing at Houghton Mifflin Inc. from 1987 to 1995. Prior to that Mr. Kanon was Chief Executive Officer of E.P. Dutton. Mr. Kanon is currently an author and has published two best-selling novels.
2003-03-10	JOSEPH KANON has served as a director of the Company since November 1999. The Audit Committee is composed of Mr. Farrell, Mr. Kanon and Mr. Quinson. The Company also has a Finance Committee to review potential equity or debt financings. Such Finance Committee consists of Mr. Graham, Ms. Stone and Mr. Kanon. The Company currently compensates its outside directors for services rendered in their capacity as directors at a rate of $1,000 per meeting. The Company's internal directors are not compensated for attendance at meetings.

Filing Date

Source Excerpt

2001-10-31

JOSEPH KANON has served as a director of the Company since November 1999. Mr. Kanon served as Executive Vice President for Trade and Reference Publishing at Houghton Mifflin Inc. from 1987 to 1995. Prior to that Mr. Kanon was Chief Executive Officer of E.P. Dutton. Mr. Kanon is currently an author and has published two best-selling novels.

2003-03-10

JOSEPH KANON has served as a director of the Company since November 1999. The Audit Committee is composed of Mr. Farrell, Mr. Kanon and Mr. Quinson. The Company also has a Finance Committee to review potential equity or debt financings. Such Finance Committee consists of Mr. Graham, Ms. Stone and Mr. Kanon. The Company currently compensates its outside directors for services rendered in their capacity as directors at a rate of $1,000 per meeting. The Company's internal directors are not compensated for attendance at meetings.

Data sourced from SEC filings. Last updated: 2026-03-05